Johnson & Johnson reports Q4 and Full-Year 2025 results

Go back to Johnson & Johnson reports Q4 and Full-Year 2025 results

Johnson & Johnson (JNJ) Meets EPS Estimate, Beats on Revenue; Offers FY Guidance

January 21, 2026 6:22 AM EST

(Updated - January 21, 2026 8:28 AM EST)

Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.46, in line with the analyst estimate of $2.46. Revenue for the quarter came in at $24.6 billion versus the consensus estimate of $24.15 billion.

GUIDANCE:

Johnson & Johnson sees FY2026... More